Volunteer For Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

Have you been diagnosed with Non-Alcoholic Steatohepatitis (NASH), and find yourself interested in learning more about new investigational developments in treating this severe form of Non-Alcoholic Fatty Liver Disease (NAFLD)? If yes, consider enrolling in Conquest Research’s latest NASH clinical trials, and become a part of the future of NAFLD treatment. Get in touch today to find out if you qualify as an eligible participant.

Get In Touch

    Eligibility Screening For Non-Alcoholic Steatohepatitis (NASH): What to Expect

    At Conquest Research, we are dedicated to aiding those who have Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH) by providing access to clinical trials that may lead to viable treatments. To ensure the utmost safety of our participants, we require all potential candidates to undergo eligibility screening. Our screening process includes:

    • We require all of our clinical trial participants to join us for a meeting with our study’s medical personnel and affiliated staff. During this meeting, we assess your present health, the severity of your condition, and determine your medical eligibility for participation.
    • Before accepting any participants, we conduct a thorough evaluation of your eligibility to ensure that you meet all inclusion criteria. This ensures that we can provide top-notch care and support throughout the clinical trial.
    • As part of the initial evaluation process, we will assess your physical, mental, and emotional health. This will include filling out study questionnaires that will enable us to gain a deeper understanding of your suitability for the clinical trial.

    All of these steps are vital measures that give our participants the best chance of success when participating in our Non-alcoholic Steatohepatitis (NASH) research.

    Non-Alcoholic Steatohepatitis (NASH) is a severe type of Non-Alcoholic Fatty Liver Disease (NAFLD), characterized by an excessive accumulation of fat in the liver. This buildup can cause inflammation and damage to the liver cells, which can lead to scarring and cirrhosis. NASH is often referred to as a “silent disease” because it can develop without any noticeable symptoms. However, some people may experience fatigue, weakness, or abdominal pain. Risk factors for NASH and NAFLD include obesity, type 2 diabetes, high cholesterol, and high blood pressure. Treatment includes lifestyle changes around weight loss, exercise, and medication options to manage symptoms and prevent further liver damage.

    nonalcoholic fatty liver disease

    Qualification Criteria For Non-Alcoholic Steatohepatitis (NASH) Clinical Trials

    To qualify for Non-Alcoholic Steatohepatitis (NASH) clinical trials, patients should satisfy specific requirements, by going through a range of assessments. Assessments can range from physical examinations to consenting to diagnostic imaging, blood work, and liver biopsies, to disclosing their medical history along with any pre-existing conditions that could affect the study. Participants will also need to satisfy inclusion criteria like being of a certain age, and having a confirmed diagnosis of NASH and certain liver-related conditions.

    Participants will also be required to complete comprehensive survey questionnaires, detailing the impact of the condition on their day-to-day life, such as changes in lifestyle, medication usage, and any other treatments they've attempted. Ultimately, this process helps guarantee the success of our NASH clinical trials and offers individuals impacted by this condition a potential chance for relief.

    If you have any questions about the qualification process, contact your trial sponsor or find out if you qualify by clicking the button below.

    Why Join a Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Through Conquest Research?

    Apart from paving the way for better health outcomes for those with NASH & NAFLD, there are certain benefits you can expect as a clinical trial participant.

    Your Travel & Related Expenses Are Reimbursed

    Participants in a Conquest Research clinical study for Non-Alcoholic Steatohepatitis (NASH) can expect reimbursement for all travel-related expenditures incurred throughout the trial. Ground transportation, airfare, hotels, meals, and other acceptable travel expenses are included. Participants are reimbursed following the completion of the clinical trial and in accordance with the clinical trial agreement given to the participant by Conquest Research. It is important for participants to keep all receipts and other documentation of their travel-related expenses to ensure proper and full reimbursement. By taking part in a NASH clinical trial, participants can contribute to medical research without being stressed about the time spent traveling to and from the clinical trial.

    Receive Novel Investigational Treatments for Non-Alcoholic Steatohepatitis (NASH)

    As a Non-Alcoholic Steatohepatitis (NASH) clinical trial participant, you will get the rare opportunity to try cutting-edge treatments before they are available to the general populace. This means you will be a direct and contributing member to the advancement of modern treatments for your condition. You also won’t be alone in this journey, as you’ll benefit from the support and connections you make with others in the clinical trial. Ultimately, your participation in a NASH clinical trial will potentially improve your overall quality of life and help you find new ways of managing your condition.

    Receive Advanced Healthcare at Free of Charge

    All participants in clinical trials for Non-Alcoholic Steatohepatitis (NASH) receive advanced healthcare treatment free of charge. Your medical tests, procedures, and medications related to the clinical trial are freely given, which is advantageous for those without healthcare insurance, or those unable to pay for current treatments on the market. There is no financial burden on you for the medical care you receive.

    Benefit From The Expertise of Renowned Medical Professionals

    Clinical trials aimed at treating Non-Alcoholic Steatohepatitis (NASH) present an exciting opportunity to benefit from the expertise of renowned medical professionals. These professionals are committed to helping patients manage their condition and participate in research that may lead to improved treatments or even a cure. Participants can expect to receive specialized care and support, as well as the latest treatments and resources. They will also receive personalized treatment plans designed to suit their specific condition and follow-up care after the trial concludes. These treatments can substantially alleviate symptoms and enhance the quality of life for individuals living with Non-Alcoholic Steatohepatitis.

    Frequently Asked Questions About Non-Alcoholic Steatohepatitis (NASH) & Clinical Trials

    Non-Alcoholic Steatohepatitis (NASH) is a type of liver disease that is caused by the buildup of fat in the liver. This buildup can cause inflammation and damage to the liver, which can ultimately lead to liver scarring and cirrhosis.
    Often with little to no symptoms in the early stages of NASH, many individuals go completely undiagnosed until the condition progresses into its later stages. During the progression period, some individuals may experience fatigue, weight loss, weakness, abdominal pain, and jaundice.
    Currently, there are no FDA-approved treatments for NASH. However, doctors may recommend lifestyle changes such as weight loss and exercise, as well as medications to manage associated conditions such as high blood pressure and high cholesterol.
    A clinical trial is a research-based study that looks to test the safety and efficacy of new medications, therapies, and medical devices on participant volunteers who are either healthy, or are diagnosed with a specific condition. Clinical trials are important in NASH research because they provide the opportunity to test new treatments for a disease that currently has no approved therapies.
    To participate in a NASH clinical trial, you will need to meet certain eligibility criteria. These criteria may include age, gender, medical history, and the stage of your disease. Conquest Research currently has a NASH clinical trial open and calling for volunteers, in which you can find here or by getting in touch on this page.

    Get Involved In Non-Alcoholic Steatohepatitis Clinical Trials

    Join us in our Non-Alcoholic Steatohepatitis [NASH] and Non-Alcoholic Fatty Liver Disease [NAFLD] clinical trials, as we find new treatments for this chronic liver disease that’s affecting millions of people worldwide. By joining in, you’ll have the opportunity to contribute to the development of new treatment options for NASH, which could improve the lives and health outcomes of those grappling with this debilitating disease. If you are someone you know is struggling with NASH, fill out the form today to see if you qualify for one of our open clinical trials.

    Get In Touch